Use of L-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes

摘要

The present invention provides the use of L-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes(NIDDM; non-insulin dependent diabetes mellitus). The present invention also provides the pharmaceutical composition containing the chemical L-2-oxothiazolidine-4-carboxylic acid as an active agent for the treatment of type 2 diabetes and the method for the treatment of type 2 diabetes comprising administering to a mammal having the same disease. Use of L-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes